Resistance training decreases plasma levels of adipokines in postmenopausal women.

Liam J Ward, Sigrid Nilsson, Mats Hammar, Lotta Lindh-Åstrand, Emilia Berin, Hanna Lindblom, Anna-Clara Spetz Holm, Marie Rubér, Wei Li
Author Information
  1. Liam J Ward: Department of Obstetrics and Gynaecology in Linköping, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. liam.ward@ki.se.
  2. Sigrid Nilsson: Department of Obstetrics and Gynaecology in Linköping, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  3. Mats Hammar: Department of Obstetrics and Gynaecology in Linköping, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  4. Lotta Lindh-Åstrand: Department of Obstetrics and Gynaecology in Linköping, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  5. Emilia Berin: Department of Obstetrics and Gynaecology in Linköping, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  6. Hanna Lindblom: Department of Health, Medicine and Caring Sciences, Unit of Physiotherapy, Linköping University, Linköping, Sweden.
  7. Anna-Clara Spetz Holm: Department of Obstetrics and Gynaecology in Linköping, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  8. Marie Rubér: Department of Obstetrics and Gynaecology in Linköping, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  9. Wei Li: Department of Obstetrics and Gynaecology in Linköping, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden. wei.li@liu.se.

Abstract

Physical inactivity and the onset of menopause increase the risk of cardiovascular disease amongst postmenopausal women. We aim to investigate the effect of resistance training (RT) on plasma levels of selected cytokines, adipokines, myokines, and sex hormones in postmenopausal women with vasomotor symptoms. This was a sub-study of a randomised controlled trial investigating the effects of RT on vasomotor symptoms in postmenopausal women. women were randomised to join a 15-week RT program (n = 26) or remain sedentary as control (n = 29). Venous blood samples were taken at week-0 and week-15 for all participants. Enzyme-linked immunosorbent assays and multiple bead assays were used to measure cytokines, adipokines, myokines, and sex hormones in plasma. Plasma measurements of 16 of 33 analytes were within detectable limits. After adjusting for good compliance in the RT group (58% of RT participants), after 15 weeks, significantly lower plasma levels of adiponectin (p < 0.001), lipocalin-2 (p < 0.01) and resistin (p = 0.04) were found. Comparing control and RT women, using change-over-time values, significant increases in median testosterone and sex hormone binding globulin levels were seen in RT women. RT intervention lowers the levels of adipokines, particularly adiponectin, in postmenopausal women with vasomotor symptoms. These results were secondary outcomes of a clinical trial, and further investigations in a larger cohort are essential with the additional control of diet control and body composition analyses. Nevertheless, our study shows RT may be a beneficial intervention in reducing inflammation amongst postmenopausal women.

References

  1. J Exerc Rehabil. 2019 Dec 31;15(6):839-847 [PMID: 31938707]
  2. J Clin Endocrinol Metab. 2008 Apr;93(4):1489-96 [PMID: 18211973]
  3. Br J Sports Med. 2002 Jun;36(3):162-72 [PMID: 12055109]
  4. Circulation. 2003 Jan 28;107(3):499-511 [PMID: 12551878]
  5. PLoS One. 2016 Jun 17;11(6):e0157417 [PMID: 27315068]
  6. Maturitas. 2010 Dec;67(4):316-20 [PMID: 20813470]
  7. Breast Cancer Res. 2015 Sep 02;17:120 [PMID: 26330303]
  8. Climacteric. 2014 Oct;17(5):540-56 [PMID: 24969415]
  9. J Strength Cond Res. 2020 Jun 17;: [PMID: 32569127]
  10. J Cardiol. 2014 Apr;63(4):250-9 [PMID: 24355497]
  11. Obesity (Silver Spring). 2010 Mar;18(3):535-41 [PMID: 19713947]
  12. Circulation. 2005 Feb 22;111(7):932-9 [PMID: 15710760]
  13. Sci Rep. 2020 Mar 2;10(1):3838 [PMID: 32123242]
  14. J Inflamm Res. 2019 Apr 26;12:99-108 [PMID: 31118735]
  15. Menopause. 2018 May;25(5):520-530 [PMID: 29206771]
  16. Front Physiol. 2020 Apr 22;11:356 [PMID: 32390865]
  17. Age (Dordr). 2016 Apr;38(2):40 [PMID: 26984105]
  18. PLoS One. 2013 Jun 17;8(6):e66607 [PMID: 23799122]
  19. Biomarkers. 2015;20(8):565-71 [PMID: 26671823]
  20. Biol Res Nurs. 2014 Jan;16(1):38-45 [PMID: 24057220]
  21. Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2457-64 [PMID: 25189569]
  22. J Womens Health (Larchmt). 2014 Feb;23(2):159-67 [PMID: 24168102]
  23. Women Health. 2013;53(3):298-316 [PMID: 23705760]
  24. Menopause. 2008 Jul-Aug;15(4 Pt 1):619-27 [PMID: 18202591]
  25. Med Sci Sports Exerc. 2012 Nov;44(11):2099-110 [PMID: 22874536]
  26. Life Sci. 2009 Jan 16;84(3-4):97-104 [PMID: 19041881]
  27. JAMA. 2002 Aug 28;288(8):980-7 [PMID: 12190368]
  28. J Nat Sci. 2017 Apr;3(4): [PMID: 28670620]
  29. Cardiovasc Diabetol. 2013 Dec 21;12:176 [PMID: 24359145]
  30. Curr Med Chem. 2012;19(32):5474-80 [PMID: 22876925]
  31. Future Cardiol. 2009 Jan;5(1):93-103 [PMID: 19371207]
  32. Biomed Res Int. 2014;2014:757461 [PMID: 24734243]
  33. Cardiovasc Diabetol. 2014 Jun 23;13:103 [PMID: 24957699]
  34. Biochem Biophys Res Commun. 2004 Feb 6;314(2):415-9 [PMID: 14733921]
  35. J Clin Endocrinol Metab. 2003 Nov;88(11):5163-8 [PMID: 14602744]
  36. Best Pract Res Clin Endocrinol Metab. 2014 Jan;28(1):59-69 [PMID: 24417946]
  37. J Sports Med Phys Fitness. 2013 Jun;53(3):289-94 [PMID: 23715254]
  38. Endocr J. 2002 Aug;49(4):503-9 [PMID: 12402983]
  39. Eur Heart J. 2006 Oct;27(19):2266-8 [PMID: 16959802]
  40. Int J Mol Sci. 2020 Feb 12;21(4): [PMID: 32059381]
  41. Lancet Neurol. 2012 Jan;11(1):82-91 [PMID: 22172623]
  42. Nutr Metab Cardiovasc Dis. 2010 Oct;20(8):608-17 [PMID: 19695853]
  43. Maturitas. 2016 Mar;85:96-103 [PMID: 26857887]
  44. Breast Cancer Res. 2018 Aug 2;20(1):81 [PMID: 30071893]
  45. Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E42-7 [PMID: 17341545]
  46. Breast Cancer Res. 2015 Nov 05;17(1):139 [PMID: 26541144]
  47. Menopause. 2008 May-Jun;15(3):536-41 [PMID: 18347511]
  48. Mayo Clin Proc. 2017 Oct;92(10):1552-1558 [PMID: 28982486]
  49. Sports Med. 2005;35(10):841-51 [PMID: 16180944]
  50. Maturitas. 2019 Aug;126:55-60 [PMID: 31239119]
  51. J Clin Transl Endocrinol. 2014 Jul 11;1(3):108-114 [PMID: 29159091]
  52. Mediators Inflamm. 2017;2017:5356020 [PMID: 29056829]
  53. Med Sci Sports Exerc. 2015 Nov;47(11):2450-5 [PMID: 25811948]
  54. Cytokine. 2006 May;34(3-4):219-23 [PMID: 16822679]
  55. Menopause. 2019 Mar;26(3):256-264 [PMID: 30277921]

MeSH Term

Adipokines
Cytokines
Female
Gonadal Steroid Hormones
Humans
Middle Aged
Postmenopause
Resistance Training

Chemicals

Adipokines
Cytokines
Gonadal Steroid Hormones

Word Cloud

Created with Highcharts 10.0.0RTwomenpostmenopausallevelsplasmaadipokinescontrolsexvasomotorsymptomsamongsttrainingcytokinesmyokineshormonesrandomisedtrialparticipantsassaysadiponectinp < 0interventionPhysicalinactivityonsetmenopauseincreaseriskcardiovasculardiseaseaiminvestigateeffectresistanceselectedsub-studycontrolledinvestigatingeffectsWomenjoin15-weekprogramn = 26remainsedentaryn = 29Venousbloodsamplestakenweek-0week-15Enzyme-linkedimmunosorbentmultiplebeadusedmeasurePlasmameasurements1633analyteswithindetectablelimitsadjustinggoodcompliancegroup58%15 weekssignificantlylower001lipocalin-201resistinp = 004foundComparingusingchange-over-timevaluessignificantincreasesmediantestosteronehormonebindingglobulinseenlowersparticularlyresultssecondaryoutcomesclinicalinvestigationslargercohortessentialadditionaldietbodycompositionanalysesNeverthelessstudyshowsmaybeneficialreducinginflammationResistancedecreases

Similar Articles

Cited By (13)